PT Phapros Tbk (ISX:PEHA) Cyclically Adjusted Revenue per Share: Rp1,334.08 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PEHA PT Phapros Tbk ISX:PEHA
74 GF Score
Price Rp262.00
GF Value Rp383.12
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is PT Phapros Tbk Cyclically Adjusted Revenue per Share?

PT Phapros Tbk ISX:PEHA -2.24% 74 Cyclically Adjusted Revenue per Share is Rp1,334.08 as of Mar. 2026. GuruFocus rates ISX:PEHA with a GF Score™ of 74/100 and a GF Value™ of Rp383.12 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PT Phapros Tbk's adjusted revenue per share for the three months ended in Mar. 2026 was Rp263.200. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is Rp1,334.08 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-30), PT Phapros Tbk's current stock price is Rp262.00. PT Phapros Tbk's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was Rp1,334.08. PT Phapros Tbk's Cyclically Adjusted PS Ratio of today is 0.20.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Phapros Tbk was 0.28. The lowest was 0.17. And the median was 0.21.


PT Phapros Tbk  (ISX:PEHA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PT Phapros Tbk's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=262.00/1334.08
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Phapros Tbk was 0.28. The lowest was 0.17. And the median was 0.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PT Phapros Tbk Cyclically Adjusted Revenue per Share Related Terms


PT Phapros Tbk Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for PT Phapros Tbk's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Phapros Tbk Cyclically Adjusted Revenue per Share Chart

PT Phapros Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PT Phapros Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1,334.08

ISX:PEHA vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Phapros Tbk's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Phapros Tbk Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Phapros Tbk's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PT Phapros Tbk's Cyclically Adjusted PS Ratio falls into.


ISX:PEHA
74GF Score
PT Phapros Tbk ISX:PEHA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Phapros Tbk Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Phapros Tbk's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=263.2/136.5387*136.5387
=263.200

Current CPI (Mar. 2026) = 136.5387.

PT Phapros Tbk Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201112 0.000 81.172 0.000
201212 0.000 84.658 0.000
201312 0.000 91.196 0.000
201412 0.000 98.819 0.000
201512 0.000 102.133 0.000
201612 0.000 105.222 0.000
201712 0.000 109.017 0.000
201803 166.705 110.097 206.743
201806 318.254 111.085 391.179
201809 344.997 111.135 423.860
201812 387.866 112.430 471.038
201903 211.721 112.829 256.213
201906 445.553 114.730 530.246
201909 292.589 114.905 347.677
201912 364.376 115.486 430.801
202003 273.058 116.252 320.707
202006 267.329 116.630 312.963
202009 293.273 116.397 344.023
202012 333.670 117.318 388.336
202103 268.204 117.840 310.763
202106 286.842 118.184 331.391
202109 358.261 118.262 413.629
202112 338.413 119.516 386.613
202203 320.547 120.948 361.866
202206 352.676 123.322 390.472
202209 370.151 125.298 403.357
202212 347.668 126.098 376.455
202303 310.683 126.953 334.143
202306 349.930 127.663 374.259
202309 267.857 128.151 285.388
202312 266.259 129.395 280.959
202403 203.623 130.607 212.871
202406 234.254 130.792 244.547
202409 243.295 130.361 254.825
202412 205.369 131.432 213.349
202503 238.894 131.948 247.205
202506 306.616 133.241 314.206
202509 268.276 133.819 273.728
202512 306.309 135.271 309.179
202603 263.200 136.539 263.200

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of Rp1,334.08 mean?
PT Phapros Tbk (ISX:PEHA) has a Cyclically Adjusted Revenue per Share of Rp1,334.08 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PT Phapros Tbk and its competitors.
Is PT Phapros Tbk's Cyclically Adjusted Revenue per Share too high?
PT Phapros Tbk's current Cyclically Adjusted Revenue per Share is Rp1,334.08. Overall, PT Phapros Tbk has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Phapros Tbk's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
PT Phapros Tbk's Cyclically Adjusted Revenue per Share of Rp1,334.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PT Phapros Tbk and its competitors. PT Phapros Tbk's current Cyclically Adjusted Revenue per Share is Rp1,334.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Phapros Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Phapros Tbk (ISX:PEHA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp383.12, compared to a current price of Rp262.00 — trading 31.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is Rp1,334.08. PT Phapros Tbk's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For PT Phapros Tbk (ISX:PEHA), the current Cyclically Adjusted Revenue per Share is Rp1,334.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued. The current stock price of Rp262.00 is trading 31.6% below its estimated GF Value™ of Rp383.12. GuruFocus considers PT Phapros Tbk to be Possible Value Trap.

Key valuation signals for ISX:PEHA:

  • Cyclically Adjusted Revenue per Share: Rp1,334.08
  • GF Value™: Rp383.12 vs. price of Rp262.00 (31.6% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Phapros Tbk Business Description

Address Jl. Dr. Ide Anak Agung Gde Agung, Menara Rajawali Lt. 17, Kuningan, Jakarta Selatan, Jakarta, IDN, 12950
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
74GF Score

Get the complete analysis for ISX:PEHA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp262.00
Price
Rp383.12
GF Value